Brain Glycoside Inosine Peptide

Brain Glycoside Inositide, as a western medicine, can be used for the treatment of central nerve injury, peripheral nerve injury type of disease. It can be used to treat stroke, neonatal hypoxic-ischemic encephalopathy, craniocerebral injury and other brain diseases, as well as Alzheimer’s disease, and spinal cord injury and other causes of central nerve injury. In addition, ceruloplasmin is also effective when used to treat peripheral nerve injuries such as diabetic peripheral neuropathy, compressive neuropathy, and traumatic and other peripheral nerve injuries. Adverse reactions such as rash, chills and fever, and nausea may occur after using this drug. It should be noted that Brain Glycoside Inositide is contraindicated in groups that are allergic to this product and any of its components, or suffer from hereditary abnormalities of glucose and lipid metabolism, acute inflammatory demyelinating polyneuropathy, and should be used with caution in people with renal insufficiency. Brain Glycoside Myosin can treat the above diseases, but should be under the guidance of a doctor to use reasonable medication, do not blindly use their own medication.